Promoting Equity and Access to MASLD Care

Description

This session covers epidemiologic trends and social determinants of health that affect access to MASLD care.

 

Journey Maps

Presentations

12:15 PM - 12:30 PM
Apr 29 2026
Washington, D.C.

Older Patients with Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) Have Higher Rates of Lean MASLD and More Advanced Fibrosis but Better Health Related Quality of Life (HRQL)

Zobair M Younossi, MD, MPH, FAASLD , Abstract Presenter
Global
MASLD
Public Health

Objectives

  • Analyze structural and social determinants of health that affect disparities in MASLD outcomes.
  • Review strategies to promote equity in MASLD care
  • Analyze structural and social determinants of health that affect disparities in MASLD management.